Mega Team - video game for Attention Deficit Hyperactivity Disorder (ADHD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Attention Deficit Hyperactivity Disorder (ADHD)+4 More
Mega Team - video game - Other
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test the effects of a cognitive-based video game intervention on children with neurodevelopmental disorders. The goal is to improve executive functioning, which includes abilities like regulating emotions, planning, and flexible thinking.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Congenital Heart Disease (CHD)
  • ASD

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Attention Deficit Hyperactivity Disorder (ADHD)

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: Baseline, Post-training study visit #1 (4-5 weeks after baseline), Post-training study visit #2 (6 months after baseline)

Month 6
Academic accuracy and efficiency
Change in Response Inhibition
Change in Working Memory
Everyday functioning and impairment
Inattentive and Hyperactivity Behaviour rated by parent and teacher
Planning and Organization

Trial Safety

Safety Progress

1 of 3

Other trials for Attention Deficit Hyperactivity Disorder (ADHD)

Trial Design

2 Treatment Groups

Control- wait list group
1 of 2
Treatment group
1 of 2
Active Control
Experimental Treatment

440 Total Participants · 2 Treatment Groups

Primary Treatment: Mega Team - video game · No Placebo Group · N/A

Treatment group
Other
Experimental Group · 1 Intervention: Mega Team - video game · Intervention Types: Other
Control- wait list groupNoIntervention Group · 1 Intervention: Control- wait list group · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, post-training study visit #1 (4-5 weeks after baseline), post-training study visit #2 (6 months after baseline)

Who is running the clinical trial?

The Governors of the University of AlbertaUNKNOWN
1 Previous Clinical Trials
200 Total Patients Enrolled
The Hospital for Sick ChildrenLead Sponsor
638 Previous Clinical Trials
6,815,652 Total Patients Enrolled
3 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
161 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Child-Bright NetworkOTHER
3 Previous Clinical Trials
530 Total Patients Enrolled
EhaveOTHER
1 Previous Clinical Trials
46 Total Patients Enrolled
Jennifer Crosbie, Ph.D., C.Psych.Principal InvestigatorThe Hospital for Sick Children

Eligibility Criteria

Age < 18 · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are 6-12 years old.
You do not have a diagnosis of ASD or CHD.
You have a clinical diagnosis of ASD supported by ADOS.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 2nd, 2021

Last Reviewed: October 17th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References